Nanoparticle Treatments Show Promise for Status Epilepticus Care
Researchers studied new ways to treat status epilepticus (SE), a serious condition where seizures last too long and can cause severe harm.
This hub covers seizure first aid: what to do during a seizure, when to use rescue meds, and when to call 911. Clear, research-informed guidance for home, school, sports, and sleep.
Yes, you can get it here! Stick it on the fridge, give it to the grandparents, and share it with teachers.
If a convulsive seizure lasts ~5 minutes, breathing is abnormal, injury occurs, itβs a first seizure, or recovery is not typical.
A written plan for caregivers/schools that includes seizure types, what to do, and when to use rescue meds.
Often yes with 1:1 close supervision, a plan, and risk discussion with your neurologist.
Showers are usually safer than baths. If using a bath, supervision matters.
Researchers studied new ways to treat status epilepticus (SE), a serious condition where seizures last too long and can cause severe harm.
This study looked at how well a combination of traditional Chinese medicine (TCM) and Western medicine works for people with refractory epilepsy (RE), which is a type of epilepsy that doesn’t respond well to standard treatments.
A study called the MonoPER study looked at how effective and tolerable the medication Perampanel (PER) is when used alone to treat adults with focal or idiopathic generalized epilepsy.
This study looked at how often and when side effects occurred in adult Asian patients with focal-onset seizures while they were treated with brivaracetam (BRV).
This study looked at the blood levels of two substances, cannabidiol (CBD) and tetrahydrocannabinol (THC), in children with epilepsy that does not respond to standard treatments.
This study looked at the effects of adding metformin, a medication commonly used for diabetes, to standard anti-seizure treatments in people with active epilepsy.
This study looked at the effects of a medication called mycophenolate mofetil (MMF) on patients with a serious condition known as anti-NMDA receptor encephalitis (NMDARE).
This study looked at how effective and safe the medication lacosamide (LCM) is for children and teenagers with drug-resistant epilepsy (DRE), which means their seizures do not respond well to standard treatments.
This study looked at how children aged 8 to 17 experience long-term video-electroencephalography monitoring (LTVEM), a procedure used to diagnose epilepsy when medications donβt work.